2006 Clinic Individual Patients 
Annals of Family Medicine
NOVEMBER 20, 2024
This can potentially compromise their ability to provide optimal patient care. ’s (2006) framework. long-term nursing homes, clinics), highlighting their perceived needs. Family physicians' pivotal role in prevention and crisis management exposes them to mental stressors due to the highly demanding circumstances.
FDA Law Blog
MARCH 7, 2024
Clissold — The trio of CDER, CBER, and CDRH released a new draft guidance titled “ Use of Data Monitoring Committees in Clinical Trials ” that revises the 2006 guidance “Establishment and Operation of Clinical Trial Data Monitoring Committees” and, when final, will replace the 2006 guidance.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Physician's Weekly
JUNE 15, 2025
The dataset, acquired between 2000 and 2018, comprised OCT and clinical metadata. The AQP4-NMOSD individuals with CVC/RF had higher ON relapse rates than those with AID (1.06 ± 3.33 Data was collected from 22 centers across North and South America, Asia, and Europe, following STROBE reporting guidelines. In MOGAD (n = 49), 40.8%
Today's Hospitalist
APRIL 24, 2025
Those interventions included standardizing both bed assignments and nursing handoffs while having ED providers—not an inpatient team—enter skeletal orders when deciding to admit a patient. Such delays can compromise patient care by increasing mortality, medical errors and length of stay. Dr. Baskin says that wasn’t a hardship.
FDA Law Blog
NOVEMBER 1, 2023
Regulating LDTs: A Long and Winding Road In what might sound to some like protesting too much, the PR invokes FDA’s longstanding assertion that IVDs “manufactured” by laboratories are medical devices and that clinical laboratories that develop tests are acting as manufacturers. FDA’s position is, however, only one side of the story.
FDA Law Blog
DECEMBER 12, 2022
Shapiro — Last summer, FDA published a draft guidance, Laser-Assisted In Situ Keratomileusis (LASIK) Lasers – Patient Labeling Recommendations (July 29, 2022) setting forth a proposal for new recommended patient‑directed labeling. The approved devices already have patient‑directed labeling that FDA has approved. By Jeffrey K.
Today's Hospitalist
JUNE 7, 2025
Medical societies and hospitals are weighing in on periprocedural concerns in patients taking GLP-1s who need procedures or surgeries. That’s according to two internists who work closely with hospitalized patients who take GLP-1s. These medications are truly life-changing for many patients.”
Expert insights. Personalized for you.
130 
Let's personalize your content